Article Versions Notes

Cillo U, Vitale A, Volk ML, Frigo AC, Feltracco P, Cattelan A, Brancaccio G, Feltrin G, Angeli P, Burra P, et al. Liver Transplantation for T2 Hepatocellular Carcinoma during the COVID-19 Pandemic: A Novel Model Balancing Individual Benefit against Healthcare Resources. Cancers. 2021; 13(6):1416. https://doi.org/10.3390/cancers13061416

Cillo, Umberto, Alessandro Vitale, Michael L. Volk, Anna Chiara Frigo, Paolo Feltracco, Annamaria Cattelan, Giuseppina Brancaccio, Giuseppe Feltrin, Paolo Angeli, Patrizia Burra, and et al. 2021. "Liver Transplantation for T2 Hepatocellular Carcinoma during the COVID-19 Pandemic: A Novel Model Balancing Individual Benefit against Healthcare Resources" Cancers 13, no. 6: 1416. https://doi.org/10.3390/cancers13061416

Cillo, U., Vitale, A., Volk, M. L., Frigo, A. C., Feltracco, P., Cattelan, A., Brancaccio, G., Feltrin, G., Angeli, P., Burra, P., Lonardi, S., Trapani, S., & Cardillo, M. (2021). Liver Transplantation for T2 Hepatocellular Carcinoma during the COVID-19 Pandemic: A Novel Model Balancing Individual Benefit against Healthcare Resources. Cancers, 13(6), 1416. https://doi.org/10.3390/cancers13061416